Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Natera Inc (NTRA)

Natera Inc (NTRA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,762,297
  • Shares Outstanding, K 69,601
  • Annual Sales, $ 257,650 K
  • Annual Income, $ -128,150 K
  • 60-Month Beta 1.43
  • Price/Sales 6.86
  • Price/Cash Flow N/A
  • Price/Book 321.59

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.57
  • Number of Estimates 3
  • High Estimate -0.52
  • Low Estimate -0.62
  • Prior Year -0.55
  • Growth Rate Est. (year over year) -3.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.65 +13.95%
on 06/04/19
26.59 -7.22%
on 06/20/19
+1.84 (+8.06%)
since 05/24/19
3-Month
17.33 +42.34%
on 05/09/19
26.59 -7.22%
on 06/20/19
+4.99 (+25.36%)
since 03/22/19
52-Week
11.08 +122.65%
on 01/08/19
29.62 -16.71%
on 08/27/18
+8.60 (+53.52%)
since 06/22/18

Most Recent Stories

More News
New ProActive(TM) Study From Natera Will Test for Rejection in 3,000 Kidney Transplant Recipients

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced a nationwide registry study for kidney transplant recipients called ProActive. This is one of the largest known prospective...

NTRA : 24.67 (-2.57%)
First Week of January 2020 Options Trading For Natera (NTRA)

Investors in Natera Inc saw new options begin trading this week, for the January 2020 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value,...

NTRA : 24.67 (-2.57%)
OncoCyte (OCX) Catches Eye: Stock Jumps 7.3%

OncoCyte (OCX) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

NTRA : 24.67 (-2.57%)
OCX : 3.88 (-9.98%)
La Jolla Pharm has the Best Relative Performance in the Biotechnology Industry (LJPC , NTRA , RDUS , FGEN , PFNX)

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

NTRA : 24.67 (-2.57%)
LJPC : 8.30 (-5.14%)
PFNX : 6.45 (-1.53%)
RDUS : 23.38 (-2.22%)
Natera Inc Shares Up 54.5% Since SmarTrend's Buy Recommendation (NTRA)

SmarTrend identified an Uptrend for Natera Inc (NASDAQ:NTRA) on February 11th, 2019 at $14.87. In approximately 3 months, Natera Inc has returned 54.47% as of today's recent price of $22.97.

NTRA : 24.67 (-2.57%)
SmarTrend Watching for Potential Pullback in Shares of Natera Inc After 7.23% Gain

Natera Inc (NASDAQ:NTRA) traded in a range yesterday that spanned from a low of $21.15 to a high of $22.77. Yesterday, the shares gained 7.2%, which took the trading range above the 3-day high of $21.87...

NTRA : 24.67 (-2.57%)
Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates

Natera (NTRA) delivered earnings and revenue surprises of 8.47% and 0.63%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

NTRA : 24.67 (-2.57%)
Natera: 1Q Earnings Snapshot

SAN CARLOS, Calif. (AP) _ Natera Inc. (NTRA) on Thursday reported a loss of $34.1 million in its first quarter.

NTRA : 24.67 (-2.57%)
Natera Reports First Quarter 2019 Financial Results

Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today reported financial results for the first quarter ended March 31, 2019 and provided...

NTRA : 24.67 (-2.57%)
New Blood Test Detects Colorectal Cancer Recurrence Up to 16.5 Months Earlier

A new clinical study shows that Natera's Signatera(TM) test identified colorectal cancer recurrence up to 16.5 months earlier than radiologic imaging by detecting traces of tumor DNA in the blood after...

NTRA : 24.67 (-2.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

See More Share

Trade NTRA with:

Business Summary

Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.

See More

Key Turning Points

2nd Resistance Point 25.79
1st Resistance Point 25.23
Last Price 24.67
1st Support Level 24.28
2nd Support Level 23.90

See More

52-Week High 29.62
Last Price 24.67
Fibonacci 61.8% 22.54
Fibonacci 50% 20.35
Fibonacci 38.2% 18.16
52-Week Low 11.08

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar